Addmedica Revenue and Competitors

Paris, FRA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Addmedica's estimated annual revenue is currently $5.4M per year.(i)
  • Addmedica's estimated revenue per employee is $201,000

Employee Data

  • Addmedica has 27 Employees.(i)
  • Addmedica grew their employee count by -44% last year.

Addmedica's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$50.7M25211%N/AN/A
#2
$18.3M91-5%N/AN/A
#3
$33.4M166-8%N/AN/A
#4
$41M20432%N/AN/A
#5
$220.1M109527%N/AN/A
#6
$54.5M2712%N/AN/A
#7
$58.1M28920%N/AN/A
#8
$19.7M98-11%N/AN/A
#9
$18.5M92-16%N/AN/A
#10
$31.6M15715%N/AN/A
Add Company

What Is Addmedica?

addmedica is a fast growing company focused on developing and marketing medical products for: • rare diseases • unmet medical needs in developed and emerging countries • serious conditions addmedica is dedicated to providing high medical value to physicians, patients, and managed care organizations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases. addmedica's strategic areas of interest comprise: • wound healing, tissue growth and cell regeneration • organ transplant, tissue replacement • genetic diseases, drug or substitute therapy, cell or gene therapy addmedica, complying with its pharmaceutical status, is proud to offer a range of products in the fields of • lung transplantation, • wound healing and deep burn care. • sickle cell disease (European Orphan Medicinal Product) addmedica is constantly looking for new opportunities and partnerships, to develop and commercialize products with high medical demand. As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading firm for the provision of medical products and innovative techniques for rare diseases with the best quality of services.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$5.4M

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Addmedica News

2022-04-17 - Global Sickle Cell Disease Drug Market 2022 Industry Insights ...

Addmedica SAS; Angiocrine Bioscience Inc; Annexin Pharmaceuticals AB; ArQule Inc; Bio Products Laboratory Ltd; Bioverativ Inc; bluebird bio Inc; Bristol-Myers...

2022-04-13 - Sickle Cell Anemia Therapeutics Market Share And Size 2022 ...

Addmedica; Gamida Cell; Glycomimetics; Pfizer; Novartis; Global Blood Therapeutics; Micelle Biopharma; Bluebird Bio; Prolong Pharmaceuticals...

2022-04-13 - Sickle Cell Disease Drug Market Size, Share, Growth 2022 ...

Addmedica SAS; Angiocrine Bioscience Inc; Annexin Pharmaceuticals AB; ArQule Inc; Bio Products Laboratory Ltd; Bioverativ Inc; bluebird bio Inc...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M27N/AN/A
#2
$2.7M27N/AN/A
#3
$2.7M27-23%N/A
#4
$2.7M27-45%N/A
#5
$2.7M2735%N/A